View in EDS

[89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer.

Saved in:
Bibliographic Details
Title: [89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer.
Authors: Lee S; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut., Cavaliere A; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut., Gallezot JD; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut., Keler T; Celldex Therapeutics, Hampton, New Jersey., Michelhaugh SK; Fralin Biomedical Research Institute, Virginia Tech Carilion School of Medicine, Roanoke, Virginia., Belitzky E; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut., Liu M; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut., Mulnix T; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut., Maher SE; Department of Immunology, Yale University, New Haven, Connecticut., Bothwell ALM; Department of Immunology, Yale University, New Haven, Connecticut.; Department of Immunobiology, University of Arizona, Tucson, Arizona., Li F; Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut., Phadke M; Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut., Mittal S; Fralin Biomedical Research Institute, Virginia Tech Carilion School of Medicine, Roanoke, Virginia.; Carilion Clinic-Neurosurgery, Roanoke, Virginia., Marquez-Nostra B; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Mar 01; Vol. 21 (3), pp. 440-447.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35027482
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: [89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Cavaliere+A%22">Cavaliere A</searchLink>; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Gallezot+JD%22">Gallezot JD</searchLink>; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Keler+T%22">Keler T</searchLink>; Celldex Therapeutics, Hampton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Michelhaugh+SK%22">Michelhaugh SK</searchLink>; Fralin Biomedical Research Institute, Virginia Tech Carilion School of Medicine, Roanoke, Virginia.<br /><searchLink fieldCode="AU" term="%22Belitzky+E%22">Belitzky E</searchLink>; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink>; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Mulnix+T%22">Mulnix T</searchLink>; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Maher+SE%22">Maher SE</searchLink>; Department of Immunology, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Bothwell+ALM%22">Bothwell ALM</searchLink>; Department of Immunology, Yale University, New Haven, Connecticut.; Department of Immunobiology, University of Arizona, Tucson, Arizona.<br /><searchLink fieldCode="AU" term="%22Li+F%22">Li F</searchLink>; Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Phadke+M%22">Phadke M</searchLink>; Yale Center for Analytical Sciences, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Mittal+S%22">Mittal S</searchLink>; Fralin Biomedical Research Institute, Virginia Tech Carilion School of Medicine, Roanoke, Virginia.; Carilion Clinic-Neurosurgery, Roanoke, Virginia.<br /><searchLink fieldCode="AU" term="%22Marquez-Nostra+B%22">Marquez-Nostra B</searchLink>; Department of Radiology and Biomedical Imaging, PET Center, Yale University, New Haven, Connecticut.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2022 Mar 01; Vol. 21 (3), pp. 440-447.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35027482
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-21-0590
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 440
    Titles:
      – TitleFull: [89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Cavaliere A
      – PersonEntity:
          Name:
            NameFull: Gallezot JD
      – PersonEntity:
          Name:
            NameFull: Keler T
      – PersonEntity:
          Name:
            NameFull: Michelhaugh SK
      – PersonEntity:
          Name:
            NameFull: Belitzky E
      – PersonEntity:
          Name:
            NameFull: Liu M
      – PersonEntity:
          Name:
            NameFull: Mulnix T
      – PersonEntity:
          Name:
            NameFull: Maher SE
      – PersonEntity:
          Name:
            NameFull: Bothwell ALM
      – PersonEntity:
          Name:
            NameFull: Li F
      – PersonEntity:
          Name:
            NameFull: Phadke M
      – PersonEntity:
          Name:
            NameFull: Mittal S
      – PersonEntity:
          Name:
            NameFull: Marquez-Nostra B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2022 Mar 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1